294 related articles for article (PubMed ID: 22922008)
1. Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn.
Doganay S; Firat PG; Cankaya C; Kirimlioglu H
Burns; 2013 Mar; 39(2):326-30. PubMed ID: 22922008
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.
Hosseini H; Nejabat M; Mehryar M; Yazdchi T; Sedaghat A; Noori F
Clin Exp Ophthalmol; 2007 Nov; 35(8):745-8. PubMed ID: 17997779
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
Su W; Li Z; Li Y; Lin M; Yao L; Liu Y; He Z; Wu C; Liang D
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9108-15. PubMed ID: 22039247
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.
Papathanassiou M; Theodossiadis PG; Liarakos VS; Rouvas A; Giamarellos-Bourboulis EJ; Vergados IA
Am J Ophthalmol; 2008 Mar; 145(3):424-431. PubMed ID: 18207123
[TBL] [Abstract][Full Text] [Related]
5. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
Yoeruek E; Ziemssen F; Henke-Fahle S; Tatar O; Tura A; Grisanti S; Bartz-Schmidt KU; Szurman P;
Acta Ophthalmol; 2008 May; 86(3):322-8. PubMed ID: 17995975
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histopathological outcomes of subconjunctival triamcinolone injection for the treatment of acute ocular alkali burn in rabbits.
Saud EE; Moraes HV; Marculino LG; Gomes JA; Allodi S; Miguel NC
Cornea; 2012 Feb; 31(2):181-7. PubMed ID: 22081154
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis.
Cheng HC; Yeh SI; Tsao YP; Kuo PC
Mol Vis; 2007 Dec; 13():2344-52. PubMed ID: 18199977
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model.
Sella R; Gal-Or O; Livny E; Dachbash M; Nisgav Y; Weinberger D; Livnat T; Bahar I
Exp Eye Res; 2016 May; 146():224-232. PubMed ID: 27020759
[TBL] [Abstract][Full Text] [Related]
9. NK1 receptor antagonists as a new treatment for corneal neovascularization.
Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
11. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
Kim TI; Kim SW; Kim S; Kim T; Kim EK
Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.
Hashemian MN; Moghimi S; Kiumehr S; Riazi M; Amoli FA
Ophthalmic Res; 2009; 42(2):90-5. PubMed ID: 19546599
[TBL] [Abstract][Full Text] [Related]
14. Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.
Hurmeric V; Mumcuoglu T; Erdurman C; Kurt B; Dagli O; Durukan AH
Cornea; 2008 Apr; 27(3):357-62. PubMed ID: 18362668
[TBL] [Abstract][Full Text] [Related]
15. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model.
Gore A; Horwitz V; Cohen M; Gutman H; Cohen L; Gez R; Kadar T; Dachir S
Exp Eye Res; 2018 Jun; 171():183-191. PubMed ID: 29548928
[TBL] [Abstract][Full Text] [Related]
16. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
Kang S; Chung SK
Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
[TBL] [Abstract][Full Text] [Related]
18. Effects of dimethyl sulfoxide on a model of corneal alkali injury.
Skrypuch OW; Tokarewicz AC; Willis NR
Can J Ophthalmol; 1987 Feb; 22(1):17-20. PubMed ID: 3815150
[TBL] [Abstract][Full Text] [Related]
19. The effect of subconjunctival suramin on corneal neovascularization in rabbits.
Lee HS; Chung SK
Cornea; 2010 Jan; 29(1):86-92. PubMed ID: 19907290
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.
Qiu F; Shin Y; Chen D; Cheng R; Chen Q; Zhou K; Larrick JW; Mendelson AR; Ma JX
Microvasc Res; 2018 Sep; 119():29-37. PubMed ID: 29630973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
